Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$386,628
+$9,794 QoQ
Shares Held
2,467
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,002
of 1,603 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Laraway Financial Advisors Inc holds $5,704,791 across 7 Drug Manufacturers - General names. NVS ranks #3 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,359 | $2,829,455 | |
| 2 | JNJ |
Johnson & Johnson
|
4,770 | $1,211,436 | |
| 3 | NVS |
Novartis AG
This page
|
2,467 | $386,628 | |
| 4 | NVO |
Novo Nordisk A S
|
7,906 | $379,013 | |
| 5 | ABBV |
AbbVie Inc.
|
1,491 | $375,195 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,729 | $350,676 | |
| 7 | PFE |
Pfizer Inc
|
7,159 | $172,388 |
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $386,628 | 2,467 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $376,834 | 2,467 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $340,125 | 2,467 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $316,368 | 2,467 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $298,531 | 2,467 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $275,021 | 2,467 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $240,063 | 2,467 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $283,754 | 2,467 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $262,636 | 2,467 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $238,632 | 2,467 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $249,092 | 2,467 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $251,288 | 2,467 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $248,944 | 2,467 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $240,764 | 2,617 | Shares | Sole | 2023-06-09 | |
| 2022-12-31 | $251,022 | 2,767 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $210,547 | 2,770 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $234,148 | 2,770 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $243,067 | 2,770 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $242,291 | 2,770 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||